IRIS UniCatt

Tumbarello, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.307
NA - Nord America 7.929
AS - Asia 4.108
SA - Sud America 336
AF - Africa 65
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 16
Totale 21.778
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.848
DE - Germania 4.031
CN - Cina 2.134
SE - Svezia 1.187
SG - Singapore 1.127
IT - Italia 829
UA - Ucraina 818
FR - Francia 532
PL - Polonia 499
IE - Irlanda 361
GB - Regno Unito 341
BR - Brasile 281
TR - Turchia 237
FI - Finlandia 232
ID - Indonesia 229
RU - Federazione Russa 185
IN - India 178
BE - Belgio 51
NL - Olanda 42
AT - Austria 39
CA - Canada 39
HK - Hong Kong 38
MX - Messico 29
IR - Iran 22
MA - Marocco 22
JP - Giappone 21
ES - Italia 19
RO - Romania 19
AR - Argentina 18
CH - Svizzera 17
IL - Israele 16
AU - Australia 14
CO - Colombia 14
CZ - Repubblica Ceca 13
VN - Vietnam 13
EU - Europa 12
GR - Grecia 12
PH - Filippine 11
LT - Lituania 10
HU - Ungheria 9
IQ - Iraq 9
BD - Bangladesh 8
BG - Bulgaria 8
CI - Costa d'Avorio 8
CL - Cile 8
EG - Egitto 8
UZ - Uzbekistan 8
BZ - Belize 7
LV - Lettonia 7
AE - Emirati Arabi Uniti 6
ZA - Sudafrica 6
AL - Albania 5
BO - Bolivia 5
DK - Danimarca 5
KR - Corea 5
KZ - Kazakistan 5
NO - Norvegia 5
PK - Pakistan 5
PT - Portogallo 5
SA - Arabia Saudita 5
VA - Santa Sede (Città del Vaticano) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EC - Ecuador 4
HR - Croazia 4
JO - Giordania 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
TN - Tunisia 4
EE - Estonia 3
ET - Etiopia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
AF - Afghanistan, Repubblica islamica di 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
CY - Cipro 2
GA - Gabon 2
KE - Kenya 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
OM - Oman 2
PE - Perù 2
RS - Serbia 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
Totale 21.770
Salva come PNG Salva come JPEG
Città #
Chandler 1.491
Singapore 630
Hangzhou 620
Jacksonville 563
Ashburn 490
San Mateo 394
Warsaw 392
Nanjing 370
Dublin 358
Ann Arbor 354
Dearborn 300
Nürnberg 266
Woodbridge 265
Wilmington 261
Jakarta 228
Izmir 205
Houston 179
Beijing 174
New York 166
Boston 161
Lawrence 137
Fairfield 136
Moscow 134
Milan 129
Seattle 129
Nanchang 127
Cattolica 121
Marseille 120
Munich 113
Kraków 104
Redwood City 101
Los Angeles 88
Princeton 79
Rome 73
Shenyang 72
Kunming 70
The Dalles 70
Chicago 67
Guangzhou 66
Bremen 65
Mountain View 61
Hebei 60
Boardman 59
Tianjin 58
Lancaster 53
Norwalk 53
Brussels 51
Zhengzhou 50
Helsinki 47
University Park 47
Cambridge 43
Jiaxing 41
Changsha 38
Redmond 37
Falls Church 36
Hong Kong 36
Frankfurt am Main 33
Pune 32
São Paulo 32
Jinan 31
Fremont 30
London 30
Leawood 28
Hefei 27
Vienna 27
Nuremberg 24
Shanghai 24
Paris 22
Augusta 21
Düsseldorf 21
Lanzhou 21
Ningbo 20
San Jose 20
Auburn Hills 19
Genova 18
Toronto 18
Cuauhtémoc 17
Andover 16
Simi Valley 16
Changchun 15
Costa Mesa 15
Portsmouth 15
Hyderabad 14
Philadelphia 14
Phoenix 14
Buffalo 13
North Bergen 13
Kish 12
Mcallen 12
Washington 12
Ottawa 11
San Diego 11
Amsterdam 10
Edinburgh 10
Kocaeli 10
Renton 10
Santa Clara 10
Bogotá 9
Detroit 9
Lauterbourg 9
Totale 11.433
Salva come PNG Salva come JPEG
Nome #
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 335
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 313
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 312
Factors associated with mortality in bacteremic patients with hematologic malignancies. 309
Factors associated with mortality in bacteremic patients with haematologic malignancies 307
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 303
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 278
A prospective survey of febrile events in hematological malignancies 262
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 247
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 246
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 240
Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients 233
Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 229
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 222
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 200
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 199
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy 195
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 184
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 182
Factors associated with mortality in bacteremic patients with hematologic malignancies. 176
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 174
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 170
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 165
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 158
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 157
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 157
Safety and effectiveness of transvenous lead extraction in octogenarians 154
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 149
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 146
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 143
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus 141
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 139
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 137
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 134
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 133
Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV infected subjects 133
Changes in incidence and risk factors of Mycobacterium avium complex infections in patients with AIDS in the era of new antiretroviral therapies 132
Neurological involvement during legionellosis, look beyond the lung 129
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in HIV-infected patients 129
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 128
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome 127
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 126
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 125
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration 125
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 124
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 124
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection 123
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 121
Attitudes and practices of dentists treating HIV patients in HAART era. 119
Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. 118
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria 117
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index 116
Attitudes and practices of dentists treating patients infected with human immunodeficiency virus in the era of highly active antiretroviral therapy 115
Bloodstream infections caused by extended -spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome 112
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 112
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 112
Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators 111
Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy 109
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 109
A prospective survey of febrile events in hematological malignancies 108
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates 107
Evaluation of the New NucliSENS EasyQ KPC test for rapid detection of Klebsiella pneumoniae carbapenemase genes (blaKPC) 107
Neurological involvement during Legionellosis, look beyond the lung 107
A prospective survey of febrile events in hematological malignancies 106
Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report 106
Oral lesions in HIV and HCV co-infected individuals in HAART era 105
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 105
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 104
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 103
Correlation between cidofovir-associated uveitis and failing immunorestoration during HAART. 102
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 102
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 102
HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy 101
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 101
Multidrug-Resistant Proteus mirabilis Bloodstream Infections: Risk Factors and Outcomes 101
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 101
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 100
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 99
Dental hygienists behaviour towards HIV-positive patients in highly active antiretroviral therapy era: a pilot survey 98
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts 98
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 98
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality 97
Uncommon yeast infections in hematological patients: from diagnosis to treatment 97
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study--authors' response 97
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 96
Meningoencephalomyelitis caused by herpes simplex virus-1 in a patient with idiopathic T CD4+ lymphocytopenia. 95
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 95
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 95
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 94
Mortality in patients with early- or late-onset candidaemia 94
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 94
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals. 94
Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. 93
Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients 92
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 91
Older HIV-positive patients in the era of highly active antiretroviral therapy: changing a scenario 90
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates. 90
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 90
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 90
Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognostic indicators 89
Totale 14.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.785
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020510 0 0 0 0 0 0 0 0 0 0 247 263
2020/20211.936 144 234 57 194 242 106 189 52 283 67 306 62
2021/20222.047 190 187 63 114 115 109 37 355 88 133 262 394
2022/20233.994 465 546 310 569 284 504 175 318 484 123 151 65
2023/20241.762 107 572 46 84 51 226 107 75 29 58 177 230
2024/20252.465 115 128 283 138 392 113 108 202 594 325 67 0
Totale 22.006